INCI Name:
Potassium Azeloyl Diglycinate


Active ingredient designed to illuminate skin complexion. Thanks to its properties, it inhibits melanin synthesis and reduces cutaneous sebum production. Azeloglicina® improves skin radiance, evenness, cutaneous elasticity and hydration. This active ingredient is suitable for greasy, seborrheic and dehydrated skin types. Recommended for a pH range from 5 to 11.

Marketing Claims 

  • Illuminating
  • Radiance
  • Brightness
  • Dark spots minimizer
  • Seboregulating
  • Soothing and softening action


Natural derivative


  • Skin lightening products
  • Anti-aging treatments
  • Hydrating and firming creams
  • Brightening serums and multifunctional formulations make-up, hair care products

Mechanism of Action

Azeloglicina® inhibits the synthesis of melanine by reducing the production of the enzyme Tyrosinase.

Key features

  • Brightens overall skin complexion after only 3 weeks
  • Reduces hyper pigmentation of dark spots 
  • Treats uneven skin tone promoting light reflection
  • Sebum regulating activity
  • Moisturizing and elasticizing activity thanks to the presence of Glycine
  • Lightens Asian skin photo types with better results compared to Kojic acid and Arbutin

Usage Dosage

3- 10%


Clear liquid

Efficacy tests

In Vitro

  • Anti-inflammatory activity (IL 1α release inhibition)
  • Melanine reduction (Tyrosinase inhibition)
  • Compared evaluation of the inhibition of VEGF (Vascular Endothelial Growth Factor) release
  • Depigmenting activity on melanocytes

In Vivo

  • Radiance on Caucasian skin photo-types
  • Radiance on Asian skin photo-types
  • Hydration, elasticity
  • Sebum normalization




  • Anti aging
  • Brightening
  • Sebum control

Confidential contents

  • Technical sheet
  • Safety sheet
  • Flyer
    (distributors reserved)
  • Formulation
    (distributors reserved)
  • Brochure
    (distributors reserved)
  • Tox Tests
    (distributors reserved)
  • Efficacy Tests
    (distributors reserved)
  • General statements
    (distributors reserved)

To view confidential content you must login: